"Huntingtin Holiday": Progress toward an Antisense Therapy for Huntington's Disease

被引：41
|
作者：
Lu, Xiao-Hong [1 ,2 ,3 ]
Yang, X. William [1 ,2 ,3 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Inst Brain Res, Los Angeles, CA 90095 USA
来源：
NEURON | 2012年 / 74卷 / 06期
关键词：
MUTANT HUNTINGTIN; MOUSE MODEL; MICE; OLIGONUCLEOTIDES; NEUROPATHOLOGY; PATHOGENESIS; BRAIN; MOTOR;
D O I：
10.1016/j.neuron.2012.06.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Lowering mutant Huntingtin is a consensus therapeutic strategy for Huntington's disease. In this issue of Neuron, Kordasiewicz et al. (2012) show the benefit of transient antisense oligonucleotide (ASO) therapy to degrade Huntingtin mRNA and elicit sustained therapeutic benefit in HD mice.
引用
收藏
页码：964 / 966
页数：3
相关论文
共 50 条
  • [21] SUMO modification of Huntingtin and Huntington's disease pathology
    Steffan, JS
    Agrawal, N
    Pallos, J
    Rockabrand, E
    Trotman, LC
    Slepko, N
    Illes, K
    Lukacsovich, T
    Zhu, YZ
    Cattaneo, E
    Pandolfi, PP
    Thompson, LM
    Marsh, JL
    SCIENCE, 2004, 304 (5667) : 100 - 104
  • [22] Targeting Huntingtin Expression in Patients with Huntington's Disease
    Tabrizi, Sarah J.
    Leavitt, Blair R.
    Landwehrmeyer, G. Bernhard
    Wild, Edward J.
    Saft, Carsten
    Barker, Roger A.
    Blair, Nick F.
    Craufurd, David
    Priller, Josef
    Rickards, Hugh
    Rosser, Anne
    Kordasiewicz, Holly B.
    Czech, Christian
    Swayze, Eric E.
    Norris, Daniel A.
    Baumann, Tiffany
    Gerlach, Irene
    Schobel, Scott A.
    Paz, Erika
    Smith, Anne V.
    Bennett, C. Frank
    Lane, Roger M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24): : 2307 - 2316
  • [23] Developing Engineered Zinc Finger Repressors of Huntingtin as a Potential Therapy for Huntington's Disease
    Zhang, H. Steve
    Paschon, David E.
    Laganiere, Josee
    Zeitler, Bryan
    Mendel, Matthew
    Cherone, Jennifer
    Yu, Qi
    Pearl, Jocelynn
    Vu, Joe
    Santiago, Yolanda
    Miller, Jeffrey C.
    Rebar, Edward J.
    Zhang, Lei
    Gregory, Philip D.
    MOLECULAR THERAPY, 2012, 20 : S68 - S68
  • [24] QUANTIFYING MUTANT HUNTINGTIN IN HUNTINGTON'S DISEASE CSF
    Wild, Edward
    Robertson, Nicola
    Miller, James
    Traeger, Ulrike
    Haider, Salman
    Macdonald, Douglas
    Langbehn, Douglas
    Kuhn, Rainer
    Weiss, Andreas
    Tabrizi, Sarah
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [25] Huntingtin Aggregates in the Olfactory Bulb in Huntington's Disease
    Highet, Blake
    Dieriks, Birger Victor
    Murray, Helen C.
    Faull, Richard L. M.
    Curtis, Maurice A.
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [26] Huntington's disease: degradation of mutant huntingtin by autophagy
    Sarkar, Sovan
    Rubinsztein, David C.
    FEBS JOURNAL, 2008, 275 (17) : 4263 - 4270
  • [27] Huntingtin proteolysis in Huntington disease
    Wellington, CL
    Ellerby, LM
    Leavitt, BR
    Roy, S
    Nicholson, DW
    Hayden, MR
    CLINICAL NEUROSCIENCE RESEARCH, 2003, 3 (03) : 129 - 139
  • [28] Huntington Disease and the Huntingtin Protein
    Zheng, Zhiqiang
    Diamond, Marc I.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES, 2012, 107 : 189 - 214
  • [29] Beyond huntingtin in Huntington disease
    不详
    NATURE GENETICS, 2004, 36 (04) : 329 - 329
  • [30] Antisense RNA therapy in Huntington's disease - Huge hope and many unknowns
    Durr, Alexandra
    M S-MEDECINE SCIENCES, 2019, 35 (11): : 834 - 836
12345